Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
11,088,335
-
Share change
-
+173,527
-
Total reported value
-
$13,748,000
-
Price per share
-
$1.24
-
Number of holders
-
33
-
Value change
-
+$1,297,526
-
Number of buys
-
18
-
Number of sells
-
14
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q1 2021
As of 31 Mar 2021,
ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,088,335 shares.
The largest 10 holders included
VANGUARD GROUP INC, Aisling Capital Management LP, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Telemetry Investments, L.L.C., CITADEL ADVISORS LLC, BARCLAYS PLC, GSA CAPITAL PARTNERS LLP, and WINTON GROUP Ltd.
This page lists
33
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.